Display options
Share it on

MMW Munch Med Wochenschr. 1980 May 23;122(21):792-4.

[Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].

MMW, Munchener medizinische Wochenschrift

[Article in German]
B R Balda, R Bassermann

PMID: 6771598

Abstract

A case of a 58 years old female is presented, who died because of a Budd-Chiari-syndrome. This complication had developed during treatment with Dacarbazine (DTIC), which was given after surgical removal of a malignant melanoma. The causative relation between the Budd-Chiari-syndrome and this cytostatic drug is discussed, even though the influence of other drugs cannot be excluded.

Substances

MeSH terms

Publication Types